Cargando…

Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach

Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Damini, Kumar, Neeraj, Singh, Aarushi, Sakharkar, Meena Kishore, Tomar, Vartika, Chandra, Ramesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Gastrointestinal Intervention 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187815/
https://www.ncbi.nlm.nih.gov/pubmed/30309202
http://dx.doi.org/10.5808/GI.2018.16.3.44
_version_ 1783363092413939712
author Sood, Damini
Kumar, Neeraj
Singh, Aarushi
Sakharkar, Meena Kishore
Tomar, Vartika
Chandra, Ramesh
author_facet Sood, Damini
Kumar, Neeraj
Singh, Aarushi
Sakharkar, Meena Kishore
Tomar, Vartika
Chandra, Ramesh
author_sort Sood, Damini
collection PubMed
description Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones: lomefloxacin, norfloxacin, ciprofloxacin, and ofloxacin have been studied. The objective of this study was to analyze the antibacterial characteristics of the different fluoroquinolones. Also, the pharmacological properties of the compounds including the Lipinski rule of five, absorption, distribution, metabolism, and excretion, LD50, drug likeliness, and toxicity were evaluated. We found that among all four FQ molecules, ofloxacin showed the highest antibacterial activity through in silico assays with a strong interaction (−38.52 kJ/mol) with the antibacterial target protein (topoisomerase-II DNA gyrase enzyme). The pharmacological and pharmacokinetic analysis also showed that the compounds ciprofloxacin, ofloxacin, lomefloxacin and norfloxacin have good pharmacological properties. Notably, ofloxacin was found to possess an IGC50 (concentration needed to inhibit 50% growth) value of 0.286 μg/L against the Tetrahymena pyriformis protozoa. It also tested negative for the Ames toxicity test, showing its non-carcinogenic character.
format Online
Article
Text
id pubmed-6187815
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Society of Gastrointestinal Intervention
record_format MEDLINE/PubMed
spelling pubmed-61878152018-10-17 Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach Sood, Damini Kumar, Neeraj Singh, Aarushi Sakharkar, Meena Kishore Tomar, Vartika Chandra, Ramesh Genomics Inform Original Article Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones: lomefloxacin, norfloxacin, ciprofloxacin, and ofloxacin have been studied. The objective of this study was to analyze the antibacterial characteristics of the different fluoroquinolones. Also, the pharmacological properties of the compounds including the Lipinski rule of five, absorption, distribution, metabolism, and excretion, LD50, drug likeliness, and toxicity were evaluated. We found that among all four FQ molecules, ofloxacin showed the highest antibacterial activity through in silico assays with a strong interaction (−38.52 kJ/mol) with the antibacterial target protein (topoisomerase-II DNA gyrase enzyme). The pharmacological and pharmacokinetic analysis also showed that the compounds ciprofloxacin, ofloxacin, lomefloxacin and norfloxacin have good pharmacological properties. Notably, ofloxacin was found to possess an IGC50 (concentration needed to inhibit 50% growth) value of 0.286 μg/L against the Tetrahymena pyriformis protozoa. It also tested negative for the Ames toxicity test, showing its non-carcinogenic character. Society of Gastrointestinal Intervention 2018-09 2018-09-30 /pmc/articles/PMC6187815/ /pubmed/30309202 http://dx.doi.org/10.5808/GI.2018.16.3.44 Text en Copyright © 2018 by the Korea Genome Organization It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Original Article
Sood, Damini
Kumar, Neeraj
Singh, Aarushi
Sakharkar, Meena Kishore
Tomar, Vartika
Chandra, Ramesh
Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
title Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
title_full Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
title_fullStr Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
title_full_unstemmed Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
title_short Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
title_sort antibacterial and pharmacological evaluation of fluoroquinolones: a chemoinformatics approach
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187815/
https://www.ncbi.nlm.nih.gov/pubmed/30309202
http://dx.doi.org/10.5808/GI.2018.16.3.44
work_keys_str_mv AT sooddamini antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach
AT kumarneeraj antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach
AT singhaarushi antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach
AT sakharkarmeenakishore antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach
AT tomarvartika antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach
AT chandraramesh antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach